{"id":382892,"date":"2020-11-17T08:33:19","date_gmt":"2020-11-17T13:33:19","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=382892"},"modified":"2020-11-17T08:33:19","modified_gmt":"2020-11-17T13:33:19","slug":"myovant-sciences-announces-new-employment-inducement-grants-under-nyse-rule-303a-08","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/myovant-sciences-announces-new-employment-inducement-grants-under-nyse-rule-303a-08\/","title":{"rendered":"Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08"},"content":{"rendered":"<div class=\"mw_release\">\n<p>BASEL, Switzerland, Nov.  17, 2020  (GLOBE NEWSWIRE) &#8212; Myovant\u00a0Sciences (NYSE:\u202fMYOV), a healthcare company focused on redefining care for women and for men,\u00a0today announced that it approved equity awards for\u00a072\u00a0new employees with a grant date of\u00a0November 15, 2020\u00a0pursuant to\u00a0Myovant\u2019s\u00a02020 Inducement\u00a0Plan. The equity awards were granted to\u00a0the\u00a0employees joining Myovant in accordance with NYSE\u2019s Listed Company Manual Rule 303A.08.\u00a0\u00a0<\/p>\n<p>The new employees received, in the aggregate, restricted stock units (RSUs) to purchase 201,400 common shares of Myovant. One-fourth of the shares underlying each employee\u2019s RSU will vest on the one-year anniversary of the grant date, with the balance of the common shares vesting in twelve equal quarterly installments thereafter, in each case, subject to each such employee\u2019s continued employment with Myovant on such vesting dates. The RSUs are subject to the terms and conditions of the 2020 Inducement Plan and the applicable restricted stock unit agreements.<\/p>\n<p>\n        <strong>About Myovant Sciences<\/strong><br \/>\n        <br \/>Myovant Sciences aspires to redefine care for women and for men through purpose-driven science, empowering medicines, and transformative advocacy. Our lead product candidate, relugolix, is a once-daily, oral GnRH receptor antagonist. Relugolix monotherapy tablet (120 mg) is under regulatory review in the U.S. for men with advanced prostate cancer. Relugolix combination tablet (relugolix 40 mg, estradiol 1.0 mg, and norethindrone acetate 0.5 mg) is under regulatory review in Europe and the U.S. for women with uterine fibroids and is under development for women with endometriosis. We are also developing MVT-602, an oligopeptide kisspeptin-1 receptor agonist, which has completed a Phase 2a study for female infertility as part of assisted reproduction. Sumitovant Biopharma, Ltd., a wholly owned subsidiary of Sumitomo Dainippon Pharma Co., Ltd., is our majority shareholder. For more information, please visit our website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=JaJhkAP_SohasPNpP4Zlz-DyhriSd0bwmgSJd4-3zV_DfNaPD4PMbnkS71ey4eVAAS7U04w6_XUNugEbrWIicw==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.myovant.com<\/a>. Follow <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Ejbu8CMJ43iYiR3uS1IuScZRy-OWrgFuLuuqdE1YEL95RZLmgVQfoGARAncJ9l_d9eNzamx5vtg5ckJpXub0iA==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">@Myovant<\/a> on Twitter and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ALjfq4Q2bSC-4HK0miZtghzdOuMKn3_FV2FtBPgk-xSEooe3EnFcJHQ-ucJG69rB2k09wfElKAhbvbNRBqEYOHcs0wB7BFTuE-M90XW_Qh0=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">LinkedIn<\/a>.<\/p>\n<p>\n        <strong>Investor Contact: <\/strong><br \/>\n        <br \/>Ryan Crowe<br \/>Vice President, Investor Relations<br \/>Myovant Sciences, Inc. <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=qwKaXNPRPLyzBIKY3656T2c8T06azKifxgt-J7t1WK7dWUCoimSPP3zZ_JGdx9xPZB9b4Tky-Kj4Z_KIhe8KgGGFiEPp1obuCoKiR2Tblcc=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">investors@myovant.com<\/a><\/p>\n<p>\n        <strong>Media Contact:<\/strong><br \/>\n        <br \/>Albert Liao<br \/>Director, Corporate Communications<br \/>Myovant Sciences, Inc.<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=mVvyt1ZDr3SmP_NWfLAtoCCxvvTmAr-RGTI-nKNlEjkV6ibg-2BGIilWjB_ZXVpO_M0asbRQ-Ka1fj5L6_Qyxw==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">media@myovant.com<\/a><\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NzM1NyMzODMwNzUxIzIxNzcyNDg=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/360a98bd-47a3-4935-b66d-feea1bd63ec1\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BASEL, Switzerland, Nov. 17, 2020 (GLOBE NEWSWIRE) &#8212; Myovant\u00a0Sciences (NYSE:\u202fMYOV), a healthcare company focused on redefining care for women and for men,\u00a0today announced that it approved equity awards for\u00a072\u00a0new employees with a grant date of\u00a0November 15, 2020\u00a0pursuant to\u00a0Myovant\u2019s\u00a02020 Inducement\u00a0Plan. The equity awards were granted to\u00a0the\u00a0employees joining Myovant in accordance with NYSE\u2019s Listed Company Manual Rule 303A.08.\u00a0\u00a0 The new employees received, in the aggregate, restricted stock units (RSUs) to purchase 201,400 common shares of Myovant. One-fourth of the shares underlying each employee\u2019s RSU will vest on the one-year anniversary of the grant date, with the balance of the common shares vesting in twelve equal quarterly installments thereafter, in each case, subject to each such employee\u2019s continued employment with Myovant on such &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/myovant-sciences-announces-new-employment-inducement-grants-under-nyse-rule-303a-08\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-382892","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/myovant-sciences-announces-new-employment-inducement-grants-under-nyse-rule-303a-08\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BASEL, Switzerland, Nov. 17, 2020 (GLOBE NEWSWIRE) &#8212; Myovant\u00a0Sciences (NYSE:\u202fMYOV), a healthcare company focused on redefining care for women and for men,\u00a0today announced that it approved equity awards for\u00a072\u00a0new employees with a grant date of\u00a0November 15, 2020\u00a0pursuant to\u00a0Myovant\u2019s\u00a02020 Inducement\u00a0Plan. The equity awards were granted to\u00a0the\u00a0employees joining Myovant in accordance with NYSE\u2019s Listed Company Manual Rule 303A.08.\u00a0\u00a0 The new employees received, in the aggregate, restricted stock units (RSUs) to purchase 201,400 common shares of Myovant. One-fourth of the shares underlying each employee\u2019s RSU will vest on the one-year anniversary of the grant date, with the balance of the common shares vesting in twelve equal quarterly installments thereafter, in each case, subject to each such employee\u2019s continued employment with Myovant on such &hellip; Continue reading &quot;Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/myovant-sciences-announces-new-employment-inducement-grants-under-nyse-rule-303a-08\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-17T13:33:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NzM1NyMzODMwNzUxIzIxNzcyNDg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myovant-sciences-announces-new-employment-inducement-grants-under-nyse-rule-303a-08\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myovant-sciences-announces-new-employment-inducement-grants-under-nyse-rule-303a-08\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08\",\"datePublished\":\"2020-11-17T13:33:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myovant-sciences-announces-new-employment-inducement-grants-under-nyse-rule-303a-08\\\/\"},\"wordCount\":330,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myovant-sciences-announces-new-employment-inducement-grants-under-nyse-rule-303a-08\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NzM1NyMzODMwNzUxIzIxNzcyNDg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myovant-sciences-announces-new-employment-inducement-grants-under-nyse-rule-303a-08\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myovant-sciences-announces-new-employment-inducement-grants-under-nyse-rule-303a-08\\\/\",\"name\":\"Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myovant-sciences-announces-new-employment-inducement-grants-under-nyse-rule-303a-08\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myovant-sciences-announces-new-employment-inducement-grants-under-nyse-rule-303a-08\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NzM1NyMzODMwNzUxIzIxNzcyNDg=\",\"datePublished\":\"2020-11-17T13:33:19+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myovant-sciences-announces-new-employment-inducement-grants-under-nyse-rule-303a-08\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myovant-sciences-announces-new-employment-inducement-grants-under-nyse-rule-303a-08\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myovant-sciences-announces-new-employment-inducement-grants-under-nyse-rule-303a-08\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NzM1NyMzODMwNzUxIzIxNzcyNDg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NzM1NyMzODMwNzUxIzIxNzcyNDg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myovant-sciences-announces-new-employment-inducement-grants-under-nyse-rule-303a-08\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/myovant-sciences-announces-new-employment-inducement-grants-under-nyse-rule-303a-08\/","og_locale":"en_US","og_type":"article","og_title":"Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08 - Market Newsdesk","og_description":"BASEL, Switzerland, Nov. 17, 2020 (GLOBE NEWSWIRE) &#8212; Myovant\u00a0Sciences (NYSE:\u202fMYOV), a healthcare company focused on redefining care for women and for men,\u00a0today announced that it approved equity awards for\u00a072\u00a0new employees with a grant date of\u00a0November 15, 2020\u00a0pursuant to\u00a0Myovant\u2019s\u00a02020 Inducement\u00a0Plan. The equity awards were granted to\u00a0the\u00a0employees joining Myovant in accordance with NYSE\u2019s Listed Company Manual Rule 303A.08.\u00a0\u00a0 The new employees received, in the aggregate, restricted stock units (RSUs) to purchase 201,400 common shares of Myovant. One-fourth of the shares underlying each employee\u2019s RSU will vest on the one-year anniversary of the grant date, with the balance of the common shares vesting in twelve equal quarterly installments thereafter, in each case, subject to each such employee\u2019s continued employment with Myovant on such &hellip; Continue reading \"Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/myovant-sciences-announces-new-employment-inducement-grants-under-nyse-rule-303a-08\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-17T13:33:19+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NzM1NyMzODMwNzUxIzIxNzcyNDg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myovant-sciences-announces-new-employment-inducement-grants-under-nyse-rule-303a-08\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myovant-sciences-announces-new-employment-inducement-grants-under-nyse-rule-303a-08\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08","datePublished":"2020-11-17T13:33:19+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myovant-sciences-announces-new-employment-inducement-grants-under-nyse-rule-303a-08\/"},"wordCount":330,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myovant-sciences-announces-new-employment-inducement-grants-under-nyse-rule-303a-08\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NzM1NyMzODMwNzUxIzIxNzcyNDg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myovant-sciences-announces-new-employment-inducement-grants-under-nyse-rule-303a-08\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/myovant-sciences-announces-new-employment-inducement-grants-under-nyse-rule-303a-08\/","name":"Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myovant-sciences-announces-new-employment-inducement-grants-under-nyse-rule-303a-08\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myovant-sciences-announces-new-employment-inducement-grants-under-nyse-rule-303a-08\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NzM1NyMzODMwNzUxIzIxNzcyNDg=","datePublished":"2020-11-17T13:33:19+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myovant-sciences-announces-new-employment-inducement-grants-under-nyse-rule-303a-08\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/myovant-sciences-announces-new-employment-inducement-grants-under-nyse-rule-303a-08\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myovant-sciences-announces-new-employment-inducement-grants-under-nyse-rule-303a-08\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NzM1NyMzODMwNzUxIzIxNzcyNDg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NzM1NyMzODMwNzUxIzIxNzcyNDg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myovant-sciences-announces-new-employment-inducement-grants-under-nyse-rule-303a-08\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/382892","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=382892"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/382892\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=382892"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=382892"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=382892"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}